Myelo Therapeutics Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 5

Myelo Therapeutics General Information


Developer of innovative adjuvant cancer therapy designed to provide the treatment for CIN. The company's therapy offers a treatment that is effective in reducing the risk of CIN in patients across various cancer types and chemotherapy regimens, enabling physicians to get benefits of improved patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Primary Office
  • Rheinsberger Strasse 7
  • 10115 Berlin
  • Germany
+49 030 00000000

Myelo Therapeutics Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Myelo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 26-Jun-2020 Completed Generating Revenue
5. Grant 11-May-2020 000 Completed Generating Revenue
4. Early Stage VC 12-Jun-2017 Completed Generating Revenue
3. Accelerator/Incubator 13-Jan-2017 Completed Generating Revenue
2. Early Stage VC (Series B) 15-Dec-2015 Completed Generating Revenue
1. Early Stage VC (Series A) 13-Apr-2013 Completed Startup
To view Myelo Therapeutics’s complete valuation and funding history, request access »

Myelo Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Till Erdmann Co-Founder, Managing Director & Chief Business Officer
Dirk Pleimes Co-Founder, Managing Director & Chief Medical Officer
To view Myelo Therapeutics’s complete executive team members history, request access »

Myelo Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Myelo Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
The Hive Venture Capital Minority 000 0000 000000 0
Vladimir Nebolsin Angel (individual) Minority 000 0000 000000 0
Eckert Life Science Accelerator Accelerator/Incubator Minority 000 0000 000000 0
Valenta Pharmaceuticals Other Minority 000 0000 000000 0
To view Myelo Therapeutics’s complete investors history, request access »